Skip to content

Predicting the Risk of Non-culprit Coronary Artery Disease After a Heart Attack

Optical Coherence Tomography With Magnetic Resonance Angiography to Assess STEMI Non-culprit Risk

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05781087
Acronym
OCT-RISK
Enrollment
90
Registered
2023-03-23
Start date
2023-04-25
Completion date
2028-09-01
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Ischemic Heart Disease, ST Elevation Myocardial Infarction

Keywords

optical coherence tomography, non-culprit, magnetic resonance imaging, cardiac magnetic resonance, STEMI, magnetic resonance angiography, OCT

Brief summary

Heart attacks caused by the complete blockage of a heart artery are treated by opening it with a stent. However, most people will also have 'non-culprit' narrowings found in their other arteries at this time. Although in general people do better if these non-culprit narrowings are also treated with stents if they look severe, this process has problems. This is because narrowings that look severe may be stable and not cause any trouble. For these people a stent is a wasted procedure and unnecessary risk. On the other hand, narrowings that are currently left alone because they appear mild, may progress and cause a heart attack. Participants who have had a heart attack will have a scan from inside the heart arteries during an angiogram (optical coherence tomography, OCT) and a magnetic resonance angiogram (MRA). If the investigators can show that it is possible to accurately predict which non-culprit narrowings are going to progress and which are going to stabilise, medical professionals may be able to better target their treatments after a heart attack.

Interventions

DIAGNOSTIC_TESTOptical coherence tomography and pressure wire assessment

Non-culprit coronary arteries

DIAGNOSTIC_TESTCardiac magnetic resonance angiogram

1.5T

Sponsors

Guy's and St Thomas' NHS Foundation Trust
Lead SponsorOTHER
King's College London
CollaboratorOTHER
Imperial College London
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Successful primary percutaneous coronary intervention (PCI) within the previous week with no major complications at the index procedure * Bystander disease in a non-culprit vessel planned for clinically indicated staged angiography +/- PCI * Able to provide written informed consent.

Exclusion criteria

* Cardiogenic shock requiring intubation, inotropes or a mechanical support device * Creatinine clearance \<30ml/min * Prior coronary artery bypass grafting * Life expectancy less than 3 years * Pregnancy. * Target lesion in the left main coronary artery * Severe calcification or tortuosity that would threaten safe placement of a pressure wire or OCT catheter * Chronic total occlusion of a major epicardial vessel.

Design outcomes

Primary

MeasureTime frame
Change in mean fibrous cap thickness measured by optical coherence tomography6 months

Secondary

MeasureTime frameDescription
Change in mean lipid arc measured by optical coherence tomography6 months
Presence of thin cap fibroatheroma measured by optical coherence tomography6 monthsPlaque with lipid arc \>90° and fibrous cap thickness ≤65µm
Change in measures of shear stress made by optical coherence tomography and magnetic resonance angiography0 and 6 monthsComparison between non-invasive and invasively derived measures

Countries

United Kingdom

Contacts

PRINCIPAL_INVESTIGATORDivaka Perera, MD

King's College London

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026